Correlation Between Verastem and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verastem and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Viridian Therapeutics, you can compare the effects of market volatilities on Verastem and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Viridian Therapeutics.
Diversification Opportunities for Verastem and Viridian Therapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verastem and Viridian is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Verastem i.e., Verastem and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Verastem and Viridian Therapeutics
Given the investment horizon of 90 days Verastem is expected to generate 1.18 times more return on investment than Viridian Therapeutics. However, Verastem is 1.18 times more volatile than Viridian Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 391.00 in Verastem on September 25, 2024 and sell it today you would earn a total of 28.00 from holding Verastem or generate 7.16% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Verastem vs. Viridian Therapeutics
Performance |
Timeline |
Verastem |
Viridian Therapeutics |
Verastem and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verastem and Viridian Therapeutics
The main advantage of trading using opposite Verastem and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.The idea behind Verastem and Viridian Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |